Login / Signup

Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial.

Jawad H ButtPardeep S JhundJan BelohlávekRudolf A de BoerChern-En ChiangAkshay S DesaiJarosław DrożdżAdrian F HernandezCatherine M ViscoliTzvetana KatovaMasafumi KitakazeMikhail Naum KosiborodCarolyn Su Ping LamAnna Maria LangkildeDaniel LindholmErasmus BachusFelipe A MartinezBela MerkelyMagnus PeterssonJose F Kerr SaraivaSanjiv J ShahMuthiah VaduganathanOrly VardenyUlrica WilderängBrian Lee ClaggettScott D SolomonJohn Joseph Valentine McMurray
Published in: Circulation (2022)
gov; Unique identifier: NCT03619213.
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • community dwelling
  • randomized controlled trial
  • open label